Background: Cortical dysfunctioning significantly contributes to the pathogenesis of motor
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Functional neuroimaging studies using positron emission tomography (PET) [1] , single-photon emission computed tomography (SPECT) [2] and functional magnetic resonance imaging (fMRI) [3] have shown that cortical dysfunctioning contributes to the pathogenesis of symptoms in
Parkinson's disease (PD). Specifically, the cortical regions that have been mostly studied are the Supplementary Motor Area (SMA), the Dorsolateral Prefrontal Cortex (DLPFC) and the Primary Motor Cortex (M1). While for M1 findings are more controversial [4] , an abnormal reduction of SMA excitability has been consistently reported and also confirmed by neurophysiological studies of the electrophysiological signature of motor preparation, such as movement-related potentials [5, 6] . Overall, several experimental evidences foster the hypothesis that SMA dysfunctioning should be taken into account to explain the pathogenesis of bradykinesia, which is the cardinal symptom of PD [7] .
A reduction of SMA activity follows the typical dopaminergic impairment within the basal ganglia that characterizes PD: this cortical area is a crucial component of the basal ganglia-thalamo-cortical circuit model, which is composed of parallel reentrant cortico-subcortical circuits spreading from specific cortical areas, passing through the basal ganglia and thalamus, and projecting back to their respective areas of origin [8, 9] . In particular, the basal ganglia [10, 11] and especially the putamen [12, 13] are densely interconnected with the motor and premotor cortex as well as the SMA. A pathological hyper-connectivity between SMA and putamen, but not with caudate, has also been shown in PD patients using a resting state fMRI approach [14] .
Therefore, several functional and anatomical characteristics of the SMA provide an empirical rationale for using this cortical area as a potential therapeutic target of neuromodulatory approaches.
Indeed, repetitive TMS (rTMS) applied over the SMA in randomized, double-blind studies has been reported to modestly improve motor symptoms in patients with PD [15, 16] , but the clinical benefit of cortical stimulation at the single patient level is still debated [17] .
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Besides its possible therapeutic use, single-pulse TMS is also suitable to investigate motor cortex dysfunctioning through motor potentials evoked by direct stimulation of M1 [7] . This conventional neurophysiologic approach has revealed an excessive corticospinal motor output at rest and a reduced facilitation of muscular activation during voluntary muscle contraction in PD patients [7, [18] [19] [20] . In this context, the combination of navigated TMS with simultaneous high-density electroencephalography (TMS/EEG) allows to non-invasively probe both local and global changes of brain excitability and connectivity [21] through the recording of TMS-evoked potentials (TEPs), which represent genuine cortical responses to a direct perturbation [22] . In addition, the neuronavigated TMS/EEG system offers the unique opportunity to target associative cortical areas,
and to obtain a direct readout of cortical function that does not involve either the cortico-spinal tract or peripheral muscle activation.
Therefore, following previous approaches aimed at detecting cortical dysfunctions in PD, TMS/EEG may be used to disclose functional properties of secondary cortical regions involved in the basal ganglia-thalamo-cortical loop and to obtain complementary information related to the complex pathophysiology of PD motor signs and symptoms.
With this aim, we measured TEPs recorded during stimulation of SMA before and after levodopa intake in PD patients. Specifically, in the present study we tested i) whether an acute levodopa intake has specific and measurable effects on cortical excitability (here referred to as the strength of the cortical response to a direct perturbation) and ii) whether these neurophysiological effects parallel the asymmetry of akinetic-rigid symptoms and the corresponding dopaminergic striatal innervation loss.
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Materials and Methods
Patient population. We enrolled thirteen patients with idiopathic PD (Table 1) , diagnosed according to the UK Parkinson Disease Brain Bank criteria [23] . All patients were on stable dopaminergic treatment for at least three months prior to this study and were showing a significant benefit from levodopa administration. Clinical assessment was performed with the Unified Parkinson Disease
Rating Scale motor part (UPDRS-III) [24] : a left and a right symptom sub-score (SS) was computed by summing the items between 22 and 26, in which a lateralized score is available [25] ( Table 1 ).
The following clinical inclusion criteria were applied: (i) UPDRS part I score of 0, (ii) Hoehn and details, refer to [27] [29] ). The brain side with lower PBR was labeled as H-, whereas the one with higher PBR was labeled as H+ (Table 1) . Within the patient population, PBR was lower on the left brain side in 7 patients (AI > 0) and on the right brain side (AI < 0) in the remaining 6 patients (Table 1 ). However, in two patients (n. 3 and n. 7) AI was lower than 10%, indicating that dopaminergic denervation was almost symmetric according to SPECT imaging. We decided to exclude patient n. 7 from group analysis because the lateralized symptom sub-score in meds-off session was not asymmetric as well (SS(left) = SS(right) = 2, Table 1 ). Conversely, we decided to include patient n. 3 into group analysis considering the left hemisphere as H-, because behavioral motor deficits were definitely prevalent on the right body side, consistent with the asymmetry direction (AI = 4.72) provided by SPECT imaging. In the remaining 11 patients, clinical assessment was congruent with SPECT imaging asymmetry (i.e. worse motor impairments contralateral to H-), except for patient n. 4 who showed higher SS score on the body side ipsilateral to H-. Since supra-threshold stimulation of the primary motor cortex produces TEPs that are also affected by a peripheral sensory feedback [32] , we always checked that stimulation intensity did not evoke muscle twitches to prevent a confounding factor. Single TMS pulses were delivered with an inter-
stimulus interval randomly jittering between 1500-1800 ms (equivalent to ca. 0.56-0.67 Hz), which does not induce any reorganization/plasticity processes possibly interfering with longitudinal measurements [31] . During TMS stimulation, patients wore in-ear headphones continuously playing a customized masking noise [33] to maximally reduce the contribution of auditory potentials elicited by TMS-associated clicks to genuine brain responses to TMS [34] .
TMS targeting. The caudal portion of the middle-superior frontal gyrus (Supplementary Motor Area
-SMA, Brodmann area -BA6) was stimulated with TMS in all patients on both brain sides. In 8 out of 12 patients (n. 1-2-3-4-6-8-11-12), the superior parietal lobule (SPL, Brodmann area -BA7) was additionally targeted bilaterally as a control region not specifically involved in the dopaminedependent cortical-basal ganglia-thalamo-cortical circuitry [9] . Supplementary Table 1 reports the MNI-transformed anatomical coordinates of the TMS hotspots in each patient (see also Figure 1B and Supplementary Figure 2 ). In each cortical target, the location of the maximum EF was always kept on the convexity of the gyrus with the induced current perpendicular to its main axis, about 1 cm lateral to the midline in order to prevent unwanted direct activation of scalp or facial muscles [35] . Homologous cortical areas of the left and right hemisphere were stimulated with the same estimated EF intensity and direction in a counterbalanced order across patients and sessions.
Therefore, either two (SMA left and right) or four (SMA left and right; SPL left and right) TMS/EEG measurements were collected in each patient during each experimental session.
Data preprocessing. Data analysis was carried out using MATLAB® (2014b, The MathWorks Inc.). Single-trial TMS-evoked potentials (TEPs) were visually inspected and artifact-contaminated trials (e.g. sporadic movement artifacts) were rejected from further analysis. EEG was band-pass filtered between 1-80 Hz, down-sampled to 725 Hz, and re-referenced to the common average reference after removal and interpolation of bad channels (always less than six and located on the scalp periphery) with the spherical method implemented in the EEGLAB toolbox [36] . The M A N U S C R I P T A C C E P T E D Computation of the Immediate Response Area. TEPs were specifically analyzed to measure cortical excitability (here referred to as the strength of the cortical response to a direct perturbation) and its modulation by acute levodopa intake; therefore, we focused data analysis on the early components of the EEG responses evoked by TMS nearby the stimulated site, similarly to [37] . used the same interval also for the corresponding meds-on session. At the group level, the following time intervals (mean ± standard deviation) were defined for the LMFP computed nearby the SMA and the SPL targets respectively: between 15.2 ± 2.76 ms and 63.4 ± 9.65 ms and between 13.8 ± 1.38 ms and 57.9 ± 11.3 ms.
In order to measure the effect of acute levodopa intake on cortical excitability, the percentage change of IRA between meds-off and meds-on sessions was computed as follows:
For each stimulated cortical region, ∆ % IRA was computed from the cluster of channels nearby the TMS target as well as from the corresponding contralateral cluster using the same time interval.
Non-parametric permutation-based statistical analysis, as described in [37] , 
Results
From a clinical perspective, as expected acute levodopa intake resulted in a significant improvement of motor symptoms in all patients (Table 1 ). In fact, at the group level we found a significant decrease of the UPDRS-III score (W(13) = -91, P = 0.0002) as well as of the SS (W(13) = -91, P = 0.0002 on the left and W(13) = -66, P = 0.001 on the right body side) in meds-on as compared to meds-off sessions.
From a neurophysiological perspective, Figure 2A shows the grandaverage TEPs and LMFPs obtained from the clusters of channels nearby the stimulated SMA in meds-off (blue) and meds-on (red) sessions (grandaverage TEPs obtained from all stimulation sites and sessions are shown in Supplementary Figure 2) . At the group level, ∆ % IRA between meds-off and meds-on sessions was significantly different from 0 only on the more affected brain side H- (Table 2 ; P < 0.01).
Specifically, ∆ % IRA nearby the stimulated SMA was significantly higher (P = 0.021) in H-than H+ ( Figure 2B ). At the single-patient level, ∆ % IRA was always significantly different from 0 nearby the stimulated SMA on the H-brain side (Table 2 ). Of note, ∆ % IRA was negative in H-and higher in H+ than H-only in one patient (n. 4), who also showed contrasting evaluations between clinical and SPECT assessments ( Table 1) .
As a control for the spatial extent of this effect, we applied the same analysis to the clusters of channels contralateral to the stimulated SMA and we did not find any significant difference (P = 0.79) of ∆ % IRA between H-and H+ sides ( Figure 3A and Table 2 ). This result suggests that levodopa intake has mainly a local effect on cortical excitability nearby SMA rather than producing global changes in brain responses to TMS. In addition, in order to control for the effect of levodopa on other brain regions, we analyzed the EEG responses to TMS of SPL: ∆ % IRA was not significantly different between H-and H+ neither nearby ( Figure 3B ; P = 0.38) nor contralateral ( Figure 3C ; P = 0.55) to the stimulated SPL (Table 2) . 
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Discussion
This study is the first to demonstrate that TMS/EEG allows non-invasively measuring the neurophysiological effects of an acute levodopa intake in cortical areas other than the primary motor cortex.
We observed that cortical excitability, as measured by the early EEG responses to TMS elicited nearby the stimulated site, significantly changes following levodopa administration. More specifically, we found that cortical excitability nearby the SMA was significantly increased ipsilateral to the more affected brain side and that this increase was higher than in the less affected hemisphere. Notably, in accordance with the very unique role of SMA in the cortico-basal-gangliathalamo-cortical circuitry, the EEG responses to TMS of the parietal cortex (SPL) were not significantly affected by levodopa intake on both sides.
Previous fMRI studies [3, 38] have shown that the hemodynamic SMA activity is abnormally reduced during meds-off condition and is relatively normalized after levodopa intake. In line with these previous imaging findings, our TMS/EEG based neurophysiological approach further confirms that levodopa replacement therapy affects the cortical activity nearby the SMA by producing an increase of the local neural response to a direct stimulation.
On the more affected brain side, the levodopa-related modulation of cortical excitability nearby the SMA was significant at the single-patient level (Table 2) : notably, the direction of this change was the same (an increase) in all but one patient, who showed a significant decrease on the more affected and increase on the less affected brain side. This pattern of "reversed excitability" was particularly interesting because only in this patient worse motor clinical signs were ipsilateral to the most affected putamen. Therefore, in this case, the modulation of cortical excitability nearby the SMA induced by acute levodopa intake was more in agreement with the clinical assessment. Since the degree of motor asymmetry can be more pronounced than the one measured by FP-CIT and M A N U S C R I P T
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SPECT [39] , other factors possibly involving non-dopaminergic derangements [40, 41] might contribute to this peculiar presentation.
Although the entire basal ganglia system is widely altered in PD, DAT measurements of the putamen returned better predictors of motor disability in comparison with equivalent measurements of the whole striatum [42, 43] . Interestingly, specific anatomical and functional connections have been reported between the putamen and the SMA in both animal [10, 44] and human studies by means of resting-state functional magnetic resonance imaging [13, 14] and diffusion tensor imaging [12] . Our study provides further evidence for this preferential relationship by showing that the levodopa-related asymmetric increase of cortical excitability nearby the SMA parallels the clinical presentation and the dopaminergic impairment of the putamen.
So far, measurements of cortical excitability in PD have been conducted by applying TMS on the primary motor cortex to measure motor threshold, motor-evoked potentials, electromyographic silent period to cortical stimulation and intracortical facilitation/inhibition [7] . The most consistent finding is an excessive corticospinal output at rest and a reduced intracortical inhibition, especially on the more affected brain side [18] : these results has been mainly interpreted as compensatory for deficiency of movement facilitation, which characterizes PD [19, 20, 45] . Our results cannot be directly compared to these previous studies because we targeted different cortical sites (i.e. SMA and SPL) and directly measured the evoked brain responses to TMS instead of the evoked peripheral activity. However, functional neuroimaging studies have associated the increase of motor cortex excitability with a concurrent hypoactivation of the SMA and have revealed that these abnormal patterns can be relatively normalized by therapy [3] . Therefore, the analysis we carried out at the single-subject level further supports the existence of pathological as well as compensatory mechanisms that involve an abnormal flow of information, reaching the SMA.
While SMA hyperactivation has been shown to predict the development and severity of levodopainduced dyskinesia [46, 47] , SMA hypoactivation has been frequently linked to the pathogenesis of bradykinesia [48] . In agreement with these hypotheses, while low-frequency inhibitory rTMS on the M A N U S C R I P T
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SMA has been shown to transiently improve involuntary movements [49] , high-frequency excitatory rTMS has been successfully applied to reduce hypokinetic symptoms in some patients, possibly by facilitating SMA activity [15, 48] .
Levodopa disposition is highly variable both within and between patients because of several peripheral and central pharmacokinetic features, which also account for its marked plasmatic concentration fluctuations over time and eventually affect the actual drug amount reaching the neural targets [38, 50, 51] . In this study, we stimulated the different cortical targets in a counterbalanced order across patients and sessions, starting about 60' after intake of the same amount of levodopa. Although the pharmacological effects on neurophysiological parameters is time-dependent, we chose to assess excitability of different cortical regions in a counterbalanced order across patients and sessions in order to prevent any bias towards specific brain region.
The present study is the first to show an asymmetric effect of levodopa intake on cortical excitability associated with the corresponding degree of dopaminergic impairment in the putamen.
We did not include a control group to evaluate the performance of a physiological dopaminergic system and the placebo effect since normative values for cortical excitability are not available:
nonetheless, the less affected hemisphere could be used as a reliable intra-individual control [38] . It would be certainly interesting to replicate and further confirm these experimental results in a selected and larger population with a more controlled and homogeneous difference between the left and right basal ganglia system.
The results reported in this study refer to the signals recorded at the scalp level: this approach allows to pool together the EEG responses to stimulation of either the H+ or the H-brain side, irrespective of specific anatomic side. Clearly, the interpretation of these results in terms of source activity locally generated at specific cortical areas is challenging because of several reasons. First, TMS pulses actually excite a patch of cortical surface as large as several cm 2 [52, 53] , thus preventing to constrain direct perturbation within a small anatomical region. Second, the electrical activity of a point-like source actually projects over several EEG electrodes as well as the signal and superior parietal lobule (SPL) on H+ and H-brain sides. H+ and H-refer to the brain side with higher and lower putamen-specific binding ratio respectively. *P < 0.05, **P < 0.01 when testing whether ∆ % IRA was significantly different from 0 (either assessed by non-parametric permutationbased statistical analysis at the single-patient level or by non-parametric Wilcoxon signed-rank at the group level). µ = group average; SE = standard error.
